SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001493152-21-023392
Filing Date
2021-09-22
Accepted
2021-09-22 17:06:47
Documents
3
Period of Report
2021-09-15
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 4.02: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-ka.htm 8-K/A 35790
2 ex16-1.htm EX-16.1 1478
3 ex16-1_001.jpg GRAPHIC 118530
  Complete submission text file 0001493152-21-023392.txt   202069
Mailing Address 125 CAMBRIDGE PARK DRIVE SUITE 301 CAMBRIDGE MA 02140
Business Address 125 CAMBRIDGE PARK DRIVE SUITE 301 CAMBRIDGE MA 02140 1 617 430 5222
Luckwel Pharmaceuticals Inc. (Filer) CIK: 0001567098 (see all company filings)

IRS No.: 461660653 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 8-K/A | Act: 34 | File No.: 333-187874 | Film No.: 211270217
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences